Top Markets
Coin of the day
Clarity Pharmaceuticals Ltd Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd

CU6
주식 순위 #11775
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company,... Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company’s lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
주가
$1.77
마지막 동기화: 2026-08-28
시가총액
$660.45M
변동 (1일)
7.26%
변동 (1년)
-9.15%
국가
AU
거래 Clarity Pharmaceuticals Ltd (CU6)

카테고리

Clarity Pharmaceuticals Ltd (CU6)의 주가 이력
최고 종가: $1.83 (2026-08-01 기준)

최저 종가: $1.06 (2021-08-01 기준)
Clarity Pharmaceuticals Ltd의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 4.14%
2025 -32.14%
2024 182.71%
2023 71.64%
2022 17.37%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$233.52 -4.71%
IE
$15.30 -23.07%
CN
$520.74 6.34%
CH
$164.39 -9.49%
CH
$2.30 -28.59%
CN